Resveratrol-calcium fructoborate combination may benefit angina patients
A combination of resveratrol and calcium fructoborate may improve markers of inflammation and heart muscle function in angina benefits, says a new study from Romania.
Archives for November 21, 2012
Study calls for maternal vitamin D supplementation
New data that ‘strongly implicates’ maternal levels of vitamin D with the risk of multiple sclerosis (MS) in children means there is now a strong case for supplementation of pregnant women in countries where sunlight levels are low between October and March.
DuPont on EU probiotic health claim ban: “Mention specific strains”
Giant of probiotic supply, DuPont, is not afraid to admit its European business has been altered by the rejection of probiotic health claims under the EU nutrition and health claims regulation (NHCR).
Mexican officials block Nestlé’s Pfizer Nutrition acquisition
Nestlé’s $11.85bn (€9bn) acquisition of Pfizer Nutrition has been blocked by Mexican competition officials over concerns that the deal could lead to price increases.
DNA analysis offers authentication for true black cohosh
A new method based on specific markers in DNA can ‘consistently’ distinguish black cohosh (Actaea racemosa) from closely related species that may be accidental or deliberate adulterants in herbal dietary supplements.
BASF bids $823m for GSK omega-3 supplier Pronova Biopharma
BASF has made a bid for Pronova Biopharma ASA, underlining its intention to become the dominant player in the pharmaceutical grade omega-3 API market.
Low barriers of entry have enabled ‘grifters, cobblers, and vermin’ to give industry bad GMP compliance press: BI chief
The industry’s big names have been complying with GMP regulations for years, but low barriers to entry have made it easy for less serious companies to do business with low GMP compliance, says the chief of BI Nutraceuticals.
‘Huge’ opportunities in the emerging cognitive health market: Enzymotec USA CEO
The cognitive health sector offers huge opportunities for dietary supplements, but it’s still evolving, says the CEO of Enzymotec USA.